Baird raised the firm’s price target on Stryker (SYK) to $405 from $378 and keeps an Outperform rating on the shares. The firm said 3Q was another solid quarter with global organic growth reaccelerating to the double-digits, orthopedic pricing turning positive for first time in a decade, and EPS growing at/above mid-teens.
Discover the Best Stocks and Maximize Your Portfolio:
- See what stocks are receiving strong buy ratings from top-rated analysts.
- Filter, analyze, and streamline your search for investment opportunities with TipRanks’ Stock Screener.